Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Iceland screens, treats, or prevents multiple myeloma (iStopMM) model shows reasonable discriminatory performance between MGUS and myeloma in a racially and ethnically diverse Bronx population.”
Title: Assessing the performance of the Iceland screens, treats, or prevents multiple myeloma (iStopMM) model in a multicultural Bronx cohort: implications for monoclonal gammopathy of undetermined significance risk stratification
Authors: Rajvi Gor, Jeevan Shivakumar, Pallavi Surana, John Wei, Irina Murakhovskaya, Mendel Goldfinger, Noah Kornblum, Lauren Shapiro, Aditi Shastri, Ridhi Gupta, David Levitz, Marina Konopleva, Eric Feldman, Kira Gritsman, R. Alejandro Sica, Ioannis Mantzaris, Amit Verma, Dennis Cooper, Murali Janakiram, Nishi Shah
You can read the Full Article on Blood Cancer Journal.
You can find more posts featuring Robert Orlowski on OncoDaily.